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Spinach glycolate oxidase (GAO) was expressed in Escherichia coil using the T7 RNA polymerase promotor. The enzyme 
accounts for approx. 1% of the soluble protein fraction and is expressed as a soluble and active enzyme. Comparison with GAO 
expressed in Saccharomyces ceretqsiae (Macheroux, P., Massey, V., Thiele, D.J. and Volokita, M. (1991) Biochemistry 30, 
4612-4619) showed that the GAO expressed in E. coli has identical physico-chemical features to the wild-type enzyme, but is 
expressed at a level approx. 15-fold higher than in the yeast system. 
Introduction 
Spinach glycolate oxidase (GAO) has been the sub- 
ject of intensive studies which led to the determination 
of the active site structure [1]. Recently, the spinach 
glycolate oxidase gene was cloned by Volokita and 
Somerville [2]. Therefore,  spinach glycolate oxidase 
became a prime candidate among flavoprotein oxidases 
to investigate the role of the amino acid residues in the 
active site by using site-directed mutagenesis. Unfortu- 
nately, glycolate oxidase expressed as a/3-galactosidase 
fusion protein was completely insoluble and hence 
inactive (Volokita and Somerville, personal communi- 
cation). Marston [3] has recently noted in a review that 
most eucaryotic polypeptides expressed as fusion pro- 
teins in Escherichia coli are insoluble. However, at- 
tempts to express active glycolate oxidase directly, un- 
der the control of the heat-inducible APL promotor, 
also gave rise to an inactive protein which was found to 
have a lower molecular weight (S6derlind and 
Lindqvist, personal communication). In both cases the 
protein was expressed in large quantities ( ~  20 mg/1 of 
cell culture). 
Correspondence to: (present address) P. Macheroux, Universit~it 
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Abbreviations: GAO, spinach glycolate oxidase; IPTG, isopropyl-/3- 
D-thiogalactopyranoside; PMSF, phenylmethanesulfonyl fluoride; 
FMN, flavin mononucleotide; SDS, sodium dodecylsulfate. 
Recently, we reported the expression of active glyco- 
late oxidase in Saccharomyces cerevisiae [4]. This ex- 
pression is under the control of the constitutive ADH 1 
promotor and the yield of the target protein is very 
low, amounting to approx. 0.07% of the total soluble 
protein fraction [4]. Although this was sufficient to 
characterize the basic properties of the enzyme it was 
clearly desirable to obtain larger quantities. Moreover, 
it was observed that the yield with some genetically 
engineered mutants was drastically reduced and we 
were unable to isolate enough material to characterize 
their physico-chemical properties. 
Heterologous proteins have been successfully ex- 
pressed in E. coli using the T7 RNA polymerase 
expression system developed by Studier and his 
coworkers [5]. Therefore,  we cloned the gene of spinach 
glycolate oxidase into such an expression system. With 
this system we achieved overexpression of soluble, ac- 
tive glycolate oxidase in E. coli which will enable us to 
study more readily active site mutants of the protein. 
In this paper we describe the construction of the new 
recombinant plasmid, demonstrate the identity of the 
enzyme expressed in E. coli with that from yeast and 
characterize the conditions under which maximal yields 
of enzyme are obtained. 
Materials and Methods 
Materials 
Restriction enzymes. Ncol  and PstI were from 
Bethesda Research Laboratories, Gaithersburg, MD 
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(BRL). BamHI and EcoRI were from Toyobo, Japan 
and BclI was from Boehringer, Indianapolis, IN. 
Antibiotics. Ampicillin, kanamycin and chloramphe- 
nicol were from Sigma, St. Louis, MO. 
Growth media. Yeast extract and bacto-tryptone 
were from Difco, Detroit, MI. Glycerol (NB grade) was 
from Boehringer. 
Other enzymes. T4 DNA ligase was from BRL and 
horseradish peroxidase was from Sigma. Sequenase 
was obtained from US Biochemicals, Cleveland, OH. 
Chemicals. o-Dianisidine, flavin mononucleotide 
(FMN), isopropyl-/3-D-thiogalactopyranoside (IPTG) 
and phenylmethanesulfonyl fluoride (PMSF) were from 
Sigma. Glycolic acid was from Aldrich, St. Louis, MO. 
Methods 
Construction of the expression plasmid. All restriction 
enzyme digestions, ligations and other common DNA 
manipulations, unless otherwise stated, were per- 
formed by standard procedures [6]. The cDNA clone of 
glycolate oxidase (GAO) contained in plasmid pGAO 
[4] was recovered by digestion with EcoRI and subse- 
quent isolation of the small 1400 bp fragment by 
agarose electrophoresis (1%) and electroblotting on 
DEAE cellulose (Schleicher & Schfill, NA 45). The 
GAO gene was then cloned into the EcoRI site of 
plasmid (+)  pBluescript (Stratagene, La Jolla, CA) 
and the orientation of the inserted gene was checked 
by digestion with PstI. In order to clone the GAO 
gene into the expression plasmid pET-3d it was neces- 
sary to introduce NcoI and BclI restriction sites at the 
5' and 3' ends, respectively. The two oligonucleotides 
used for the directed mutagenesis are shown in Fig. 1. 
The mutagenesis was performed with the Amersham 
mutagenesis system, version 2 (Amersham Corpora- 
tion, Arlington Heights, IL) and all steps were carried 
out as described in the protocol. The two silent muta- 
tions were introduced in two consecutive mutagenesis 
experiments. The sequence of the entire gene was then 
verified by single-strand dideoxy sequencing using the 
Sequenase sequencing system (USB, Cleveland, OH). 
The plasmid, isolated from E. coil strain GMll9 [7], 
was then digested with BclI and partially with NcoI; 
the 1150 bp fragment, containing the full length se- 
quence of the GAO gene, was isolated as described 
above. Plasmid pET-3d was digested with NcoI and 
BamHI and the large fragment was isolated and puri- 
fied in the same way. The silently mutated GAO gene 
was now inserted into the NcoI-BamHI restriction 
fragment of the expression vector using T4 DNA lig- 
Nco I 
A 
a) TAT ATE AGC AGA CCA TGG AGA TCA CAA ATG TG 
', ~ ', 
I I I 
-10 1 10 
Bcl I 
b) GAA ACe TAT GTT TGA T'CA ACG GAA ATG 
I I , ', , 
I I 
1140 1150 1160 
Fig. 1. The two oligonucleotides for introducing Ncol and BclI 
restriction sites, are shown, respectively. The nucleotides which 
caused the mutation of the original sequence are boldfaced and 
underlined. The position of the nucleotides in the sequence of the 
glycolate oxidase gene are given below the oligonucleotide sequence. 
The NcoI site was introduced at position - 1, just upstream of the 
ATG start codon. The BclI site was created 42 nucleotides down- 
stream from the termination codon. 
ase. The strategy used to clone the GAO gene into the 
T7 RNA polymerase expression vector is outlined in 
Fig. 2. 
Microbiological manipulations. TB-medium [6] was 
used for all bacterial cultures. Where required ampi- 
cillin (100 #g/ml)  and chloramphenicol (50 p.g/ml) 
were added. Plasmid pBluescript was propagated in E. 
coli strain XLl:blue [8] or strain GMll9. Strain 
HMS174 was used to propagate plasmid pPM1 and 
strain BL21 (DE3)/pLysS [5] was used for expression 
of the spinach glycolate oxidase. All necessary transfor- 
mations were carried out with the calcium chloride 
method as described in the literature [6]. Single-strand 
DNA for sequencing and the mutagenesis experiments 
was produced by infecting XL1 :blue transformants 
with the helper phage M13KO7 using standard proce- 
dures [6]. 
Purification of GAO derived from E. coli. Cells from 
a 1 I growth were harvested by centrifugation at 20000 
× g for 20 min and the pellet was resuspended in 30 
ml 0.1 M Tris buffer (pH 8), containing 1 mM EDTA, 
0.5 mM FMN and 0.5 mM PMSF. The cells were 
immediately frozen and stored at - 20°C for at least 15 
h and then thawed. Due to the presence of lysozyme in 
the cells, freezing and thawing was an efficient method 
of achieving complete lysis. The viscosity of the result- 
ing lysate, owing to the presence of uncleaved DNA, 
was reduced by adding DNase to a final concentration 
of 3 p.g/ml and incubated for 60 rain at 25°C. This 
Fig. 2. Strategy for cloning the gene of glycolate oxidase into expression plasmid pET-3d. The steps are described in detail in the text. 
Abbreviations used in this figure are as follows: P, T7 promotor; T, T7 terminator; GAO,  the gene of spinach glyeolate oxidase; Ap, ampicillin 
resistance; Tc, tetracyclin resistance; ADHIp ,  alcohol dehydrogenase promotor; CYC1 T, termination signal from the yeast iso-l-cytochrome c 
gene; TRP1, tryptophane synthetase gene. 
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Purification of spinach glycolatc oxMase expressed in Escherichia coli 
Purification Volume Protein content b Activity ~ Specific activity Yield Purification 
step (ml) (mg/ml)  ( ~ O D / m i n )  ( ~ / m i n  × OD2~ o ) (%) (n-fold) 
Crude extract " 35 27.5 0.18 0.007 100 I 
Dialysis 40 24 0.15 0.00625 95 0.9 
Hydroxyapatite (pool) lg 3.36 0.234 0.069 67 10 
Q-sepharose (pool) 1.5 0.73 2.2 3 52 430 
" Crude extract was prepared from 14 g of cells. Expression of GAO was induced at OD00~ = 1 and cells were harvested after 4 h. 
~' Protein concentration was estimated by assuming that an OD2s 0 of 1 equals 1 mg/ml  protein. 
Activity was determined by using the enzyme-coupled assay described in Materials and Methods. 
crude extract was centrifuged at 40 000 × g for 30 min 
and the supernatant decanted and dialyzed against 
three changes of 1 I 5 mM Tris buffer (pH 8.3), 
containing 1 mM EDTA. The enzyme was then puri- 
fied on hydroxyapatite and Q-sepharose as described 
previously [4]. Details of a typical preparation are 
summarized in Table I. 
Enzyme assay. Glycolate oxidase activity was mea- 
sured in an enzyme-coupled assay using horseradish 
peroxidase and o-dianisidine to utilize hydrogen perox- 
ide generated during oxidation of glycolate. A typical 
assay mixture contained 10 Ixl of horseradish peroxi- 
dase (1 mg/ml),  50 p.1 of o-dianisidine solution (8 mM, 
20% Triton X-100), 10 txl of 1 M sodium glycolate, and 
930/xl of 0.1 M potassium phosphate buffer (pH 8.3). 
The reaction was started by adding 10 ixl of the glyco- 
late oxidase sample. Formation of the o-dianisidine 
radical cation (6440 = 11 600 M i c m  1), which reflects 
the catalytic activity of glycolate oxidase, was moni- 
tored at 440 nm and at 25°C. 
Amino acid sequence determination. N-terminal se- 
quence determination was performed with an Applied 
Biosystems 470 gas-phase sequenator, and carried out 
by the Protein Sequence Facility, University of Michi- 
gan. 
Results and Discussion 
Expression of spinach glycolate oxidase in E. coli 
Spinach glycolate oxidase is expressed in E. coli in a 
soluble and active form using the T7 DNA polymerase 
directed expression system described by Studier and 
coworkers [5]. Upon induction of the expression system 
with IPTG the enzyme could be detected on SDS-poly- 
acrylamide gel electrophoresis (Fig. 3) as well as by its 
enzymatic activity. Since expression of heterologous 
proteins in E. coli frequently yields insoluble protein 
(inclusion bodies) (see, for example, Ref. 9) we com- 
pared the proteins of the supernatant with the proteins 
of the pellet by SDS-gel electrophoresis (data not 
shown). From this comparison it was obvious that most 
if not all of the expressed GAO was contained in the 
supernatant, i.e., it is soluble. 
Identity of spinach glycolate oxidase from different ex- 
pression systems 
GAO expressed in E. cog could be purified using 
the same procedure that was described for spinach 
GAO expressed in Saccharomyces cerevisiae [4]. In 
both chromatographic steps the enzyme expressed in 
E. cog exhibited the same binding properties as the 
TABLE 11 
Comparison of K,,,-calues and specific activities of glycolate oxidases &olated from various sources 
Values were taken from the following publications: 10, Zelitch and Ochao, 1953; 11, Frigerio and Harbury, 1958; 12, Kerr and Groves, 1975; 13, 
Nishimura et al., 1983. 
Spinach Yeast-derived E. coli-derived Pea leaves Pumpkin cotyledon 
GAO spinach GAO spinach GAO GAO GAO 
K m for glycolate ~ 
(mM) 0.38 (30°C) 1o 0.25 (25°C) 0.2 (25°C) 0.25 (30°C) t2 0.33 (35°C) i.~ 
Specific activity 
( ,amol/min per mg) 9.6 (30°C) i i 31 (25°C 26 (25°C) 30 (30oc) I2 40 (35oc) 13 
~' All K m values reported here were determined at air saturation. 
enzyme expressed in yeast (see Table I). After homo- 
geneity was achieved the specific activity of the E. 
coli-derived enzyme was nearly the same as that ob- 
served for enzyme derived from yeast. Table II gives a 
comparison of the Km-values for glycolate and the 
specific activities of glycolate oxidases purified from 
various sources. The K m values compiled in Table II 
are all in a narrow range (between 0.2 and 0.38 raM). 
With the exception of the value of the specific activity 
reported for glycolate oxidase isolated from spinach 
[11] the specific activities found for the recombinant 
spinach enzymes are similar to those found for the 
enzyme from pea leaves [12] and pumpkin cotyledons 
[13]. 
The ultraviolet-visible spectrum of recombinant 
GAO from both sources was identical (data not shown). 
Although these findings indicate that the enzymes ex- 
pressed in E. coli and in yeast are identical, we were 
concerned about a recent report [14] that flavocy- 
tochrome b 2 is expressed in E. coli as a somewhat 
smaller protein lacking the first five N-terminal amino 
acids. Since GAO is closely related to flavocytochrome 
b 2 (up to 40% sequence identity, Ref. 15) we found it 
important to make sure that no such truncation occurs 
with GAO. Furthermore,  S6derlind and Lindqvist (per- 
sonal communication) attempted to express GAO un- 
der the control of the )tPL promotor in E. coli but 
observed that a substantially smaller protein was pro- 
duced. SDS gel electrophoretic comparison of GAO 
isolated from E. coli and yeast, respectively, did not 
reveal any differences in apparent molecular weight 
1 2 3 4 5 
~'--GAO 
Fig. 3. Expression of spinach glycolate oxidase in E. coli strain BL 21 
(DE 3). The SDS-gel electrophoresis shown in the figure demon- 
strates the expression of spinach glycolate oxidase in E. coli. The 
lanes contained the following samples: lane 1, s tandard proteins 
(molecular weights are given on the left); lane 2, purified spinach 
glycolate oxidase from E. coli; lane 3, cell extract before induction 
with IPTG; lane 4, cell extract 2 h after induction with IPTG and 
lane 5, cell extract 4 h after induction with IPTG. 
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TABLE III 
Expression of  glycolate oxidase as a function o f  time 
1 I TB medium containing 100 / zg /ml  ampicillin and 50 /xg /ml  
chloramphenicol was inoculated with BL21 (DE3) carrying plasmids 
pLysS and pPM1. Expression of G A O  was induced with IPTG (final 
concentration 400 IzM) at an OD~00 of 0.8. At the times given below 
100 ml samples were taken and a crude extract was prepared as 
described in Materials and Methods.  G A O  activity was determined 
in the crude extract employing the enzyme coupled assay (see Mate- 
rials and Methods) and the absorbance at 280 nm was used as a 
measure  of protein concentration. 
Time Specific activity× 10 3 








but since small changes cannot be detected with that 
method we subjected a purified sample of GAO de- 
rived from E. coli to an N-terminal protein sequence 
determination. The result showed that the first ten 
amino acids of GAO derived from E. coli matched the 
N-terminal sequence determined for the spinach en- 
zyme [2,16]. Black et al. [14] suggested that the expres- 
sion of a truncated flavocytochrome b 2 is due to trans- 
lation initiation at a putative Shine-Delgarno sequence 
that comprises the first amino acid of the mature 
protein. In contrast to the expression plasmid used for 
flavocytochrome b 2, pPM1 (see Fig. 2) provides an 
optimal Shine-Delgarno sequence with the right spac- 
ing to the ATG-starting codon of the GAO-gene, which 
probably prevents formation of fortuitous complexes 
between the mRNA of GAO and the 16S rRNA. 
Optimization of growth conditions 
Fig. 3 suggests that GAO might accumulate for 
more than 4 h after induction, as was also reported for 
other proteins [5]. In order to determine the optimal 
time of induction we measured the enzymatic activity 
over 22 h after addition of IPTG (final concentration 
400/xM). The results are summarized in Table III. The 
enzyme activity increases steadily with the time of 
growth after induction with IPTG and reaches a maxi- 
mum after approx. 18-20 h. This finding implies that 
the GAO is not toxic for the cells since plasmids which 
produce toxic gene products are eliminated readily 
within a few generations of bacterial growth. On the 
other hand the expression of GAO is low compared to 
other proteins which have been produced by this ex- 
pression system to as much as 50% of the total soluble 
protein [17]. The reasons for this broad range of ex- 
pression levels are still not fully understood. The possi- 
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TABLE IV 
hzduction o f  glvcolate oxidase expression as a fimction ~[" cell density 
Three flasks each with 1 1 TB medium containing 100 ~ g / m l  
ampicillin and 50 /~g/ml chloramphenicol were inoculated with 
BL21 (DE3) carrying plasmids pLysS and pPM1. At OD~,o0 of 0.2, (1.6 
and 1.0, respectively, expression of GAO was induced with IPTG 
(final concentration 400 p~M). After 2 and 4 h 100 ml samples were 
taken and crude extracts were prepared as described in Materials 
and Methods. GAO activity in the crude extract was determined with 
the enzyme coupled assay (see Materials and Methods) and the 
OO2st} was used as an estimate for protein concentration. 
Induction Induction Activity Specific activity× 1[) -~ 
at OD~,~x } (h) ( A O D ×  ( A O D × m i n  l/OD2~0) 
rain E ) 
(1.2 2 0 
4 0 - 
0.6 2 0.024 0.42 
4 [).045 0.97 
l.ll 2 0.17(1 3.2 
4 0.335 5.8 
ble factors involved have been summarized recently 
[18]. 
Another factor which might affect the expression is 
the concentration of the inducer. Studier and cowork- 
ers [5] used 400 /zM IPTG in their protocol. Since 
IPTG is a rather costly component we decided to 
investigate the dependency of the expression system on 
the IPTG concentration. We found that in the range of 
25 to 400 ~ M  final concentration of IPTG the expres- 
sion level was independent of the inducer concentra- 
tion. 
In order to further optimize the conditions for ex- 
pression we induced the bacterial cultures at various 
cell densities. After 2 and 4 h of induction, respec- 
tively, the activity and specific activity was measured. 
Induction of the culture at a low cell density (OD600 of 
0.2) completely failed to turn on the expression of 
GAO. At higher cell densities ( O D 6 0 0  = 0.6 and 1.0) 
expression occurred and was highest at OD600 = 1. At 
the same time the specific activity was also optimal at 
OD600 = 1. A summary of this experiment is given in 
Table IV. After induction of a culture at  O D 6 0 0  = 1 
and growth for ~ 18-20 h (see above) GAO accounts 
for ~ 1% of the soluble protein. 
In comparison with the expression of GAO as a 
/3-galactosidase fusion protein and the expression with 
the heat inducible A PL promotor the yield achieved 
here was considerably lower. However, in contrast, the 
newly constructed expression plasmid pPM1 provides 
soluble and active GAO in amounts sufficient for fur- 
ther physicochemical and rapid reaction investigations 
of wild-type and mutant glycolate oxidases. 
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